Index of reports
> Cases with Pneumonia (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mesna where reactions include pneumonia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-22
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Other drugs received by patient: Zokzid; Metronidazole; Albuminar-20; Sodium Chloride 0.9%; Diflucan; Meropenem; 5% Glucose; Furosemide
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-19
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Other drugs received by patient: Furosemide; Albuminar-20; Zokzid; Diflucan; 5% Glucose; Meropenem; Metronidazole; Sodium Chloride 0.9%
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-15
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Blood PH Decreased, Haemoglobin Decreased, Haematocrit Decreased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Circulatory Collapse, Platelet Count Decreased, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Other drugs received by patient: Diflucan; Albuminar-20; Metronidazole; Zokzid; Meropenem; 5% Glucose; Furosemide; Sodium Chloride 0.9%
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-06-14
Patient: male, weighing 58.0 kg (127.6 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Other drugs received by patient: Metronidazole; Meropenem; Furosemide; Zokzid; Diflucan; Sodium Chloride 0.9%; Albuminar-20; 5% Glucose
Possible Mesna side effects in male
Reported by a physician from Poland on 2012-05-31
Patient: male, weighing 62.0 kg (136.4 pounds)
Reactions: Pneumonia, Circulatory Collapse, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Etoposide
Dosage: 96mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Cytosar-U
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-17
Mesna
Dosage: 128mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Ofatumumab
Dosage: 1000mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
Ifosfamide
Dosage: 1600mg cyclic
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-05-16
End date: 2012-05-20
Other drugs received by patient: Metronidazole; Zokzid; 5% Glucose; Furosemide; Diflucan; Sodium Chloride 0.9%; Meropenem; Albuminar-20
Possible Mesna side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02
Patient: 31 year old male
Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 420 mg, unk
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituxan
Dosage: 788 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Doxorubicin HCL
Dosage: 103 mg, unk
Indication: non-Hodgkin's Lymphoma
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 6.3 g, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 618 mg, unk
Indication: non-Hodgkin's Lymphoma
Leucovorin Sodium
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Mesna
Dosage: 1236 mg, unk
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix
Possible Mesna side effects in male
Reported by a physician from United States on 2012-01-30
Patient: male
Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Neulasta
Indication: Product Used FOR Unknown Indication
Leucovorin Calcium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Mesna
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Methotrexate
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Cytarabine
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Ciprofloxacin; Voriconazole; Fluconazole; Protonix; Valtrex; Medrol
Possible Mesna side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-24
Patient: 31 year old male
Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mesna
Indication: non-Hodgkin's Lymphoma
Rituximab
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Methotrexate
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Leucovorin Calcium
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Vincristine Sulfate
Indication: non-Hodgkin's Lymphoma
Pegfilgrastim
Indication: Product Used FOR Unknown Indication
Cytarabine
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Fluconazole; Voriconazole; Ciprofloxacin; Medrol; Pantoprazole; Valtrex
Possible Mesna side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-19
Patient: 31 year old male
Reactions: Pneumonia, Fatigue, Syncope, Anaemia, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 103 mg, unk
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 618 mg, unk
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 420 mg, unk
Indication: non-Hodgkin's Lymphoma
Leucovorin Sodium
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Mesna
Dosage: 1236 mg, unk
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituximab
Dosage: 788 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 6.3 g, unk
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Protonix; Medrol; Voriconazole; Valtrex; Ciprofloxacin; Fluconazole
Possible Mesna side effects in male
Reported by a individual with unspecified qualification from United States on 2011-12-19
Patient: male
Reactions: Fatigue, Syncope, Pneumonia, Hypotension, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Leucovorin Calcium
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Mabthera
Cytarabine
Dosage: 6.3 g, x4
Indication: non-Hodgkin's Lymphoma
Leucovorin Calcium
Dosage: 15 mg, q6h
Administration route: Oral
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mesna
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 1680 mg, unk
Mabthera
Dosage: 788 mg, unknown
Indication: non-Hodgkin's Lymphoma
Methotrexate
Dosage: 420 mg, unk
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Medrol; Fluconazole; Protonix; Ciprofloxacin; Valtrex
Possible Mesna side effects in male
Reported by a physician from United States on 2011-10-26
Patient: male, weighing 65.8 kg (144.8 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia, Vomiting, Nausea, Hypotension, Pyrexia, Headache, Hypokalaemia, Fatigue
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ifosfamide
Dosage: 24.775 g
Mesna
Dosage: 24.75 g
Etoposide
Dosage: 875 mg
|